Cyfra21-1在宫颈癌新辅助化疗疗效评价中的作用 |
| |
引用本文: | 钟倩,刘婉敏,张伟健,练晓勤,王海清,刘芳.Cyfra21-1在宫颈癌新辅助化疗疗效评价中的作用[J].中国现代医生,2010,48(15):5-6. |
| |
作者姓名: | 钟倩 刘婉敏 张伟健 练晓勤 王海清 刘芳 |
| |
作者单位: | 广东省江门市中心医院妇科,广东江门,529000 |
| |
摘 要: | 目的 探讨细胞角蛋白19片段抗原21—1(Cyfra21—1)检测在宫颈癌新辅助化疗疗效评价中的作用。方法应用电化学发光法检测53例健康人、60例CIN1—3级患者、56例宫颈癌患者血清Cyfra21—1和对需行新辅助化疗的44例宫颈癌患者化疗前后的血清Cyfra21—1进行比较。结果宫颈癌患者的血清Cyfra21-1与健康人、CIN1—3患者血清Cyfra21-1值的差异有统计学意义(P〈0.05),但健康人与CIN1—3患者血清Cyfra21—1值的差异无统计学意义(P〉0.05);化疗前后血清Cyfra21—1值有统计学意义(P〈0.05);化疗后肿块缩小的程度与血清Cyfra21—1下降程度有统计学意义,血清Cyfra21-1下降50%,表明肿块缩小至少25%。结论血清Cyfra21-1的检测对评价宫颈癌患者新辅助化疗效果具有肯定的临床意义。
|
关 键 词: | Cyfra21-1 宫颈癌 新辅助化疗(NACT) |
Role of Cyfra21-1 Detection in Evaluation of Cervical Cancer New Adjuvant Chemotherapy |
| |
Authors: | ZHONG Qian LIU Wanmin ZHANG Weijian LIAN Xiaoqin WANG Haiqing LIU Fang |
| |
Institution: | (Guangdong Province Jiangmen City Central Hospital,Jiangmen 529000, China) |
| |
Abstract: | Objective To investigate the role of the cytokeratin 19 fragment antigen 21-1 ( Cyfra21-1 ) level detection in the evaluation of cervical cancer new adjuvant chemotherapy. Methods Serum Cyfra21-1 level was detected in 53 healthy adults and 60 cases of CIN1-3 and 56 cases of cervical cancer by chemiluminescence immunoassay and the serum Cyfra21-1 level in 44 cases of cervical cancer by neo-adjuvant chemotherapy was compared before and after chemotherapy. Results There were significant differences between serum Cyfra21-1 level in cervical cancer and serum Cyfra21-1 levels in healthy people and CIN 1-3 cases (P〈 0.05 ), and no significant difference in serum Cyfra21-1 level between the healthy people and CIN1-3 cases(P〉0.05). There was a significant difference in serum Cyfra21-1 level before chemotherapy compared With post-chemotherapy serum Cyfra21-1 level(P〈0.05). There was a significant difference between post-chemotherapy tumor size and serum Cyfra21-1 level. When serum Cyfra21-1 level decreased by 50% ,the tumor size shrunk by at least 25%. Conclusion The serum Cyfra2-1 level detection is of great value in evaluating cervical cancer neoadjuvant chemotherapy. |
| |
Keywords: | cyfra21-1 |
本文献已被 维普 万方数据 等数据库收录! |